Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GOLDHIRSCH A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 167 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kitchen, PRB; Smith, HJ; Henderson, MA; Goldhirsch, A; Castiglione-Gertsch, M; Coates, AS; Gusterson, B; Brown, RW; Gelber, RD; Collins, JP
      Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy

      ANZ journal of surgery
    2. Colleoni, M; Gelber, RD; Gelber, S; Castiglione-Gertsch, M; Coates, AS; Goldhirsch, A
      How to improve timing and duration of adjuvant chemotherapy

      BREAST
    3. Thurlimann, B; Price, KN; Castiglione, M; Coates, AS; Goldhirsch, A; Gelber, RD; Forbes, J; Holmberg, S; Veronesi, A; Bernhard, J; Zahrieh, D
      Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93

      BREAST
    4. Bonetti, M; Gelber, RD; Goldhirsch, A; Castiglione-Gertsch, M; Coates, AS
      Features that predict responsiveness to chemotherapy and endocrine therapies

      BREAST
    5. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
      Quality of life scores predict outcome in metastatic but not in early breast cancer

      BREAST
    6. Curigliano, G; Ferretti, G; Colleoni, M; Marrocco, E; Peruzzotti, G; De Cicco, C; Paganelli, G; Goldhirsch, A
      Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms

      ANNALS OF ONCOLOGY
    7. Crivellari, D; Pagani, O; Veronesi, A; Lombardi, D; Nole, F; Thurlimann, B; Hess, D; Borner, M; Bauer, J; Martinelli, G; Graffeo, R; Sessa, C; Goldhirsch, A
      High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

      ANNALS OF ONCOLOGY
    8. Nole, F; Munzone, E; Mandala, M; Catania, C; Orlando, L; Zampino, MG; Minchella, I; Colleoni, M; Peruzzotti, G; Marrocco, E; Goldhirsch, A
      Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study

      ANNALS OF ONCOLOGY
    9. Gelber, S; Coates, AS; Goldhirsch, A; Castiglione-Gertsch, M; Marini, G; Lindtner, J; Edelmann, DZ; Gudgeon, A; Harvey, V; Gelber, RD
      Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    10. Colleoni, M; Gelber, S; Coates, AS; Castiglione-Gertsch, M; Gelber, RD; Price, K; Rudenstam, CM; Lindtner, J; Collins, J; Thurlimann, B; Holmberg, SB; Cortes-Funes, H; Simoncini, E; Murray, E; Fey, M; Goldhirsch, A
      Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    11. Goldhirsch, A; Glick, JH; Gelber, RD; Coates, AS; Senn, HJ
      Meeting highlights: International consensus panel on the treatment of primary breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    12. Colleoni, M; Goldhirsch, A; Coates, A; Gelber, R; Castiglione-Gertsch, M
      Bone metastases in breast cancer: How to prevent? In reply

      JOURNAL OF CLINICAL ONCOLOGY
    13. Curigliano, G; Ferretti, G; Flamini, G; Goldhirsch, A; de Braud, F; Calabro, MG; Mandaly, M; Nole, F; De Pas, T; D'Addessi, A; Cittadini, A
      Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradientgel electrophoresis urinalysis

      ANTICANCER RESEARCH
    14. De Pas, T; de Braud, F; Mandala, M; Curigliano, G; Catania, C; Ferretti, G; Sozzi, P; Solli, P; Goldhirsch, A
      Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine

      LUNG CANCER
    15. Cole, BF; Gelber, RD; Gelber, S; Coates, AS; Goldhirsch, A
      Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis

      LANCET
    16. Biffi, R; De Braud, F; Orsi, F; Pozzi, S; Arnaldi, P; Goldhirsch, A; Rotmensz, N; Robertson, C; Bellomi, M; Andreoni, B
      A randomized, prospective trial of central venous ports connected to standard open-ended or groshong catheters in adult oncology patients

      CANCER
    17. Mancuso, P; Burlini, A; Pruneri, G; Goldhirsch, A; Martinelli, G; Bertolini, F
      Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

      BLOOD
    18. Ferretti, G; Curigliano, G; Pastorino, U; Cittadini, A; Flamini, G; Calabro, MG; De Pas, T; Orlando, L; Mandala, M; Colleoni, M; Spaggiari, L; Granone, PL; Pagliari, G; de Braud, F; Fazio, N; Goldhirsch, A
      Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    19. Colleoni, M; Orlando, L; Nole, F; Goldhirsch, A
      Introducing taxanes in the adjuvant treatment of breast cancer: expectations and reality

      BREAST
    20. Castiglione-Gertsch, M; Gelber, RD; O'Neill, A; Coates, AS; Goldhirsch, A
      Systemic adjuvant treatment for premenopausal node-negative breast cancer

      EUROPEAN JOURNAL OF CANCER
    21. Piccart, M; Goldhirsch, A; Straehle, C
      The Breast International Group: a new spirit of collaboration in breast cancer research for the new millennium

      EUROPEAN JOURNAL OF CANCER
    22. Pagani, O; Sessa, C; Nole, F; Crivellari, D; Lombardi, D; Thurlimann, B; Hess, D; Borner, M; Bauer, J; Martinelli, G; Graffeo, R; Zucchetti, M; D'Incalci, M; Goldhirsch, A
      Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study

      ANNALS OF ONCOLOGY
    23. Colleoni, M; Minchella, I; Mazzarol, G; Nole, F; Peruzzotti, G; Rocca, A; Viale, G; Orlando, L; Ferretti, G; Curigliano, G; Veronesi, P; Intra, M; Goldhirsch, A
      Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors

      ANNALS OF ONCOLOGY
    24. De Pas, T; de Braud, F; Danesi, R; Sessa, C; Catania, C; Curigliano, G; Fogli, S; del Tacca, M; Zampino, G; Sbanotto, A; Rocca, A; Cinieri, S; Marrocco, E; Milani, A; Goldhirsch, A
      Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    25. Roth, AD; Maibach, R; Martinelli, G; Fazio, N; Aapro, MS; Pagani, O; Morant, R; Borner, MM; Herrmann, R; Honegger, H; Cavalli, F; Alberto, P; Castiglione, M; Goldhirsch, A
      Docetaxel (Taxotere (R))-cisplatin (TC): An effective drug combination in gastric carcinoma

      ANNALS OF ONCOLOGY
    26. Graffeo, R; Pagani, O; Crivelli, M; Zappa, F; Borella, P; Reiner, M; Goldhirsch, A
      Parathyroid hormone-related protein in metastatic breast cancer induced hypercalcemia: A case report

      ANNALS OF ONCOLOGY
    27. Orlando, L; Colleoni, M; Nole, F; Biffi, R; Rocca, A; Curigliano, G; Ferretti, G; Peruzzotti, G; de Braud, F; Masci, G; Goldhirsch, A
      Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?

      ANNALS OF ONCOLOGY
    28. Crivellari, D; Bonetti, M; Castiglione-Gertsch, M; Gelber, RD; Rudenstam, CM; Thurlimann, B; Price, KN; Coates, AS; Hurny, C; Bernhard, J; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Goldhirsch, A
      Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII

      JOURNAL OF CLINICAL ONCOLOGY
    29. Colleoni, M; Bonetti, M; Coates, AS; Castiglione-Gertsch, M; Gelber, RD; Price, K; Rudenstam, CM; Lindtner, J; Collins, J; Thurlimann, B; Holmberg, S; Veronesi, A; Marini, G; Goldhirsch, A
      Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors

      JOURNAL OF CLINICAL ONCOLOGY
    30. Colleoni, M; O'Neill, A; Goldhirsch, A; Gelber, RD; Bonetti, M; Thurlimann, B; Price, KN; Castiglione-Gertsch, M; Coates, AS; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Rudenstam, CM
      Identifying breast cancer patients at high risk for bone metastases

      JOURNAL OF CLINICAL ONCOLOGY
    31. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
      Quality-of-life scores predict outcome in metastatic but not early breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    32. Sabbioni, MEE; Siegrist, HP; Bacchi, M; Bernhard, J; Castiglione, M; Thurlimann, B; Bonnefoi, H; Perey, L; Herrmann, R; Goldhirsch, A; Hurny, C
      Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment

      BREAST CANCER RESEARCH AND TREATMENT
    33. Colleoni, M; Mandala, M; Peruzzotti, G; Robertson, C; Bredart, A; Goldhirsch, A
      Depression and degree of acceptance of adjuvant cytotoxic drugs

      LANCET
    34. Aebi, S; Gelber, S; Castiglione-Gertsch, M; Coates, AS; Goldhirsch, A
      False negatives in oestrogen-receptor assay - Reply

      LANCET
    35. Goldhirsch, A; Francis, P; Castiglione-Gertsch, M; Gelber, RD; Coates, AS
      Taxanes as adjuvant for breast cancer

      LANCET
    36. Aebi, S; Gelber, S; Castiglione-Gertsch, M; Gelber, RD; Collins, J; Thurlimann, B; Rudenstam, CM; Lindtner, J; Crivellari, D; Cortes-Funes, H; Simoncini, E; Werner, ID; Coates, AS; Goldhirsch, A
      Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

      LANCET
    37. Bertolini, F; Paolucci, M; Peccatori, F; Cinieri, S; Agazzi, A; Ferrucci, PF; Cocorocchio, E; Goldhirsch, A; Martinelli, G
      Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma - Reply

      BRITISH JOURNAL OF HAEMATOLOGY
    38. Munzone, E; Nole, F; Orlando, L; Mandala, M; Biffi, R; Ciano, C; Villa, G; Civelli, M; Goldhirsch, A
      Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patients

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    39. Bernhard, J; Castiglione-Gertsch, M; Schmitz, SFH; Thurlimann, B; Cavalli, F; Morant, R; Fey, MF; Bonnefoi, H; Goldhirsch, A; Hurny, C
      Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonaltreatment

      EUROPEAN JOURNAL OF CANCER
    40. Colleoni, M; Orvieto, E; Nole, F; Orlando, L; Minchella, I; Viale, G; Peruzzotti, G; Robertson, C; Noberasco, C; Galimberti, V; Sacchini, V; Veronesi, P; Zurrida, S; Orecchia, R; Goldhirsch, A
      Prediction of response to primary chemotherapy for operable breast cancer

      EUROPEAN JOURNAL OF CANCER
    41. Goldhirsch, A
      Postoperative radiotherapy 'improves survival' in postmenopausal breast cancer - Comment

      EUROPEAN JOURNAL OF CANCER
    42. Sabbioni, MEE; Castiglione, M; Hurny, C; Siegrist, HP; Bacchi, M; Bernhard, J; Thurlimann, B; Bonnefoi, H; Perey, L; Goldhirsch, A; Senn, HJ
      Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients

      SUPPORTIVE CARE IN CANCER
    43. Nole, F; Minchella, I; Colleoni, M; Orvieto, E; Munzone, E; de Braud, F; Peruzzotti, G; Martinelli, G; Zampino, MG; Catania, C; Pizzamiglio, M; Veronesi, P; Zurrida, S; Galimberti, V; Goldhirsch, A; Veronesi, U
      Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)

      ANNALS OF ONCOLOGY
    44. Pagani, O; Sessa, C; Martinelli, G; Crivellari, D; Buonadonna, A; Thurlimann, B; Hess, D; Borner, M; Bauer, J; Zampino, G; Zimatore, M; Graffeo, R; Riva, A; Goldhirsch, A
      Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

      ANNALS OF ONCOLOGY
    45. Colombo, T; Parisi, I; Zucchetti, M; Sessa, C; Goldhirsch, A; D'Incalci, M
      Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin

      ANNALS OF ONCOLOGY
    46. De Pas, T; Martinelli, G; De Braud, F; Peccatori, F; Catania, C; Aapro, MS; Goldhirsch, A
      Friedreich's ataxia and intrathecal chemotherapy in a patient with lymphoblastic lymphoma

      ANNALS OF ONCOLOGY
    47. Locatelli, M; Colleoni, M; Noberasco, C; Nole, F; Orlando, L; Munzone, E; Peruzzotti, G; Goldhirsch, A
      Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (cmf regimen)

      ANNALS OF ONCOLOGY
    48. Bernhard, J; Thurlimann, B; Schmitz, SFH; Castiglione-Gertsch, M; Cavalli, F; Morant, R; Fey, MF; Bonnefoi, H; Goldhirsch, A; Hurny, C
      Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?

      JOURNAL OF CLINICAL ONCOLOGY
    49. Cote, RJ; Peterson, HF; Chaiwun, B; Gelber, RD; Goldhirsch, A; Castiglione-Gertsch, M; Gusterson, B; Neville, AM
      Role of immunohistochemical detection of lymph-node metastases in management of breast cancer

      LANCET
    50. Colleoni, M; Price, KN; Castiglione-Gertsch, M; Gelber, RD; Coates, AS; Goldhirsch, A
      Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil

      LANCET
    51. Bredart, A; Didier, F; Robertson, C; Scaffidi, E; Fonzo, D; Costa, A; Goldhirsch, A; Autier, P
      Psychological distress in cancer patients attending the European Instituteof Oncology in Milan

      ONCOLOGY
    52. Bertolini, F; Paolucci, M; Peccatori, F; Cinieri, S; Agazzi, A; Ferrucci, PF; Cocorocchio, E; Goldhirsch, A; Martinelli, G
      Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

      BRITISH JOURNAL OF HAEMATOLOGY
    53. PAGANI O; ONEILL A; CASTIGLIONE M; GELBER RD; GOLDHIRSCH A; RUDENSTAM CM; LINDTNER J; COLLINS J; CRIVELLARI D; COATES A; CAVALLI F; THURLIMANN B; SIMONCINI E; FEY M; PRICE K; SENN HJ
      PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI

      European journal of cancer
    54. COLLEONI M; NOLE F; MINCHELLA I; NOBERASCO C; LUINI A; ORECCHIA A; VERONESI P; ZURRIDA S; VIALE G; GOLDHIRSCH A
      PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY IN BREAST-CANCER

      European journal of cancer
    55. COLLEONI M; PRICE K; CASTIGLIONEGERTSCH M; GOLDHIRSCH A; COATES A; LINDTNER J; COLLINS J; GELBER RD; THURLIMANN B; RUDENSTAM CM
      DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER

      European journal of cancer
    56. GOLDHIRSCH A
      ADJUVANT SYSTEMIC TREATMENT FOR OPERABLE BREAST-CANCER STANDARD THERAPIES AND NEW APPROACHES

      European journal of cancer
    57. PINDER SE; MURRAY S; ELLIS IO; TRIHIA H; ELSTON CW; GELBER RD; GOLDHIRSCH A; LINDTNER J; CORTESFUNES H; SIMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M
      THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE

      European journal of cancer
    58. COLLEONI M; MINCHELLA I; ORVIETO E; PERUZZOTTI G; NOLE F; VIALE G; NOBERASCO C; SACCHINI V; VERONESI P; ORECCHIA R; GOLDHIRSCH A
      PREDICTION OF RESPONSE TO PRIMARY CHEMOTHERAPY (PCT) FOR OPERABLE BREAST-CANCER

      European journal of cancer
    59. NOLE F; MUNZONE E; ZAMPINO MG; MINCHELLA I; COLLEONI M; NOBERASCO C; DEPAS T; FAZIO N; DEBRAUD F; PERUZZOTTI G; GOLDHIRSCH A
      CONTINUOUS-INFUSION OF 5-FLUOROURACIL (CIFU) GIVEN WITH VINORELBINE (VI) AND CISPLATIN (P) (VIFUP) IN HEAVILY PRETREATED METASTATIC BREAST-CANCER

      European journal of cancer
    60. PAGANI O; SESSA C; MARTINELLI G; CRIVELLARI D; GOLDHIRSCH A
      DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)

      European journal of cancer
    61. GELBER RD; GELBER S; BONETTI M; GOLDHIRSCH A
      QUALITY-OF-LIFE ASSESSMENT IN THE ADJUVANT SETTING - IS IT RELEVANT

      European journal of cancer
    62. PICCART MJ; BIGANZOLI L; GOLDHIRSCH A
      EORTC AND BIG TRIALS

      European journal of cancer
    63. JUNGI WF; BERNHARD J; HURNY C; SCHMITZ SFH; HANSELMANN S; GUSSET H; PESTALOZZI D; GOLDHIRSCH A
      EFFECT OF CARBOPLATIN ON RESPONSE AND PALLIATION IN HORMONE-REFRACTORY PROSTATE-CANCER

      Supportive care in cancer
    64. GOLDHIRSCH A; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
      NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION

      Annals of oncology
    65. DEPAS T; DEBRAUD F; ORLANDO L; NOLE F; MUNZONE E; ZAMPINO MG; FAZIO N; AAPRO MS; GOLDHIRSCH A
      HIGH-DOSE IFOSFAMIDE PLUS ADRIAMYCIN IN THE TREATMENT OF ADULT ADVANCED SOFT-TISSUE SARCOMAS - IS IT FEASIBLE

      Annals of oncology
    66. BIFFI R; DEBRAUD E; ORSI E; POZZI S; MAURI S; GOLDHIRSCH A; NOLE F; ANDREONI B
      TOTALLY IMPLANTABLE CENTRAL VENOUS ACCESS PORTS FOR LONG-TERM CHEMOTHERAPY - A PROSPECTIVE-STUDY ANALYZING COMPLICATIONS AND COSTS OF 333 DEVICES WITH A MINIMUM FOLLOW-UP OF 180 DAYS

      Annals of oncology
    67. GOLDHIRSCH A; COLLEONI M; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
      ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE

      Annals of oncology
    68. BORNER MM; CASTIGLIONE M; BACCHI M; WEBER W; HERRMANN R; FEY MF; PAGANI O; LEYVRAZ S; MORANT R; PESTALOZZI B; HANSELMANN S; GOLDHIRSCH A
      THE IMPACT OF ADDING LOW-DOSE LEUCOVORIN TO MONTHLY 5-FLUOROURACIL INADVANCED COLORECTAL-CARCINOMA - RESULTS OF A PHASE-III TRIAL

      Annals of oncology
    69. COLLEONI M; ORLANDO L; ROBERTSON C; NOLE F; PERUZZOTTI G; CASSANO R; ORVIETO E; VIALE G; GOLDHIRSCH A
      ASSESSMENT OF RESPONSE IN PRIMARY CHEMOTHERAPY FOR BREAST-CANCER

      Annals of oncology
    70. COLLEONI M; ORVIETO E; NOLE F; ORLANDO L; VIALE G; PERUZZOTTI G; SACCHINI V; VERONESI P; ORECCHIA R; GOLDHIRSCH A
      FACTORS PREDICTIVE OF RESPONSE TO PRIMARY CHEMOTHERAPY FOR OPERABLE BREAST-CANCER

      Annals of oncology
    71. NOBERASCO C; PERUZZOTTI G; COLLEONI M; NOLE F; DEBRAUD F; MARTINELLI G; GOLDHIRSCH A
      HEPATIC TOXICITY DURING ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN BREAST-CANCER

      Annals of oncology
    72. NOLE F; COLLEONI M; DEBRAUD F; ZAMPINO MG; MINCHELLA I; ORLANDO L; VERONESI P; SACCHINI V; GOLDHIRSCH A
      PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER (OBC) USING A REGIMEN WITH A LOW SUBJECTIVE TOXIC BURDEN CONTAINING VINORELBINE (V), 5-FLUOROURACIL (FU) AND FOLINIC ACID (FA)

      Annals of oncology
    73. PAGANI O; SESSA C; VANDENBULCKE T; MARTINELLI G; ZAMPINO G; NOLE F; ZIMATORE M; LOCATELLI M; CRIVELLARI D; BUONADONNA A; THURLIMANN B; HESS D; BORNER M; BAUER J; RIGGI M; RIVA A; GOLDHIRSCH A
      DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)

      Annals of oncology
    74. ROTH AD; MAIBACH R; MORANT R; PAGANI O; DEBRAUD F; BORNER MM; STUPP R; HERRMANN R; FAZIO N; SESSA C; GOLDHIRSCH A
      TAXOTERE-CISPLATIN-5FU (TCF) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PHASE I-II STUDY

      Annals of oncology
    75. MUNZONE E; DEBRAUD F; BAGLIETTO L; ORLANDO L; GOLDHIRSCH A
      CA-19.9 SERUM MARKER AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY (CT) IN LOCALLY ADVANCED (LA) AND METASTATIC (M) PANCREATIC-CANCER (PC) PATIENTS

      Annals of oncology
    76. FAZIO N; DEBRAUD F; COLLEONI M; ORSI F; GRASSO F; MARENGHI C; DEPAS T; GASPARETTO M; NOLE F; GOLDHIRSCH A
      HEPATIC INTRAARTERIAL CHEMOTHERAPY (HIAC) WITH FLUOROURACIL, CISPLATIN AND MITOMYCIN-C IN PRIMARY AND SECONDARY LIVER-TUMORS VIA PERCUTANEOUS CATHETER - A FEASIBILITY STUDY

      Annals of oncology
    77. ZAMPINO MG; LOCATELLI M; DECOBELLI O; RUSSO R; SBANOTTO A; MARTINELLI G; DEBRAUD F; GOLDHIRSCH A
      HIGH-DOSE FOSFESTROL (F) CONTINUOUS-INFUSION (CI) IN OUTPATIENT SETTING OF HORMONE-REFRACTORY PROSTATIC-CANCER (HRPC)

      Annals of oncology
    78. DEPAS T; DEBRAUD F; SESSA C; NOLE F; MINCHELLA I; CATANIA C; GOLDHIRSCH A
      PHASE-I STUDY USING WEEKLY TAXOL (T) AND GEMCITABINE (G) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)

      Annals of oncology
    79. GINSBURG AD; LEVINE MN; BOWMAN DM; OLIVOTTO IA; FIELDS LA; LITTLE CD; CANTIN J; MCGREGOR M; GOLDHIRSCH A; BRAMWELL V; GELMON K; BRYCE C; ALLAN S; NORRIS B; LATREILLE J; PATERSON ADH; TOMIAK E; TREMBLAY G; BAIRD R; BECKER P; BUTTS C; DANCEY JT; GOEL R; KVERN B; MILNE C; NAROD S; NOLAN E; THURLOW WH; WONG R
      ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER

      CMAJ. Canadian Medical Association journal
    80. COLE BF; SOLALCELIGNY P; GELBER RD; LEPAGE E; GISSELBRECHT C; REYES F; SEBBAN C; SUGANO D; TENDLER C; GOLDHIRSCH A
      QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING

      Journal of clinical oncology
    81. COLLEONI M; MARTINELLI G; BERETTA F; MARONE C; GALLINO A; FONTANA M; GRAFFEO R; ZAMPINO G; DEPAS T; CIPOLLA G; MARTINONI C; GOLDHIRSCH A
      INTRACAVITARY CHEMOTHERAPY WITH THIOTEPA IN MALIGNANT PERICARDIAL-EFFUSIONS - AN ACTIVE AND WELL-TOLERATED REGIMEN

      Journal of clinical oncology
    82. GOLDHIRSCH A; COATES AS; COLLEONI M; CASTIGLIONEGERTSCH M; GELBER RD
      ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE

      Journal of clinical oncology
    83. COLE BF; GELBER RD; GOLDHIRSCH A
      CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY

      Journal of clinical oncology
    84. COLLEONI M; COATES A; PAGANI O; GOLDHIRSCH A
      COMBINED CHEMOENDOCRINE ADJUVANT THERAPY FOR PATIENTS WITH OPERABLE BREAST-CANCER - STILL A QUESTION

      Cancer treatment reviews
    85. COATES AS; GELBER RD; GOLDHIRSCH A
      SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW

      Lancet
    86. PARMAR MKB; TORRI V; BONAVENTURA A; BONAZZI C; COLOMBO N; DELALOYE JF; MARSONI S; MANGIONI C; SANDERCOCK J; SESSA C; WILLIAMS C; TINAZZI A; FLANN M; GEISER K; SCORPIGLIONE N; STEWART JF; CHAVES J; PALMEIRO E; CURTAIN A; MCCORMACK T; GENNATAS C; MARRAS F; OPPO TG; BALESTRINO M; MALZONI C; MALZONI M; BELLI M; GEMINIANI ML; CRESTANI G; MONACO A; VAVALA V; PIATTO E; BARATTINI G; FORNARA PG; CHETRI MC; SANTEUFEMIA G; ARTIOLI F; CARONE D; FANIZZA G; TRENTADUE R; PRIOLO D; SCOLLO P; NIGRO SC; PETRINA M; MASTRANTONIO P; SPANNA GD; ZAGNI R; BELLONI C; COLLEONI R; REDAELLI L; CAVAGNINI A; DICOSTANZO G; PERRONI D; ARIENTI S; ORFANOTTI G; CANTONI FM; SECLI R; BIANCHI A; MARTINELLO R; MOLLICA G; MAIZZI D; PICCHIARELLI ME; FIORINI G; BORSANI M; COLOMBO E; GARSIA S; MELGRATI L; PAGGI G; BRUNENGHI GM; CASINI M; ISA L; ALGERI R; PROZIO G; BELFIORE G; ANGELINI F; DAPRILE M; MORESCHI M; MAURI ML; NATALE N; SENZANI FM; PAVANATO G; POGGI G; GARUTI G; LUERTI M; CRUCIANI G; PAGANO F; BACCOLO M; PODDI ER; BOCCIOLONE L; SABELLI MA; MAGGI R; RESTELLI C; DANTONA A; LOCATELLI MC; PESSI A; RAINA A; CHIARI S; GABRIELE A; PITTELLI MR; IACOBELLI P; DOGLIOTTI L; GORZEGNO G; MUSSO P; VEGNA G; COCO G; ALLETTI DG; PICCIOTTO F; LUCCHESE V; EPIS A; DIPALUMBO VS; DRUDI G; RAVAIOLI A; ZAMPELLA D; MORANDI MG; GORGA G; ZUCCHELLI C; CARIELLO S; GALLETTO L; SUSSIO M; MASSACESI L; MASSACESI M; CARLI A; TUCCI E; TAJANI E; CORRADO G; BUMMA S; DURANDO A; MASSOBRIO M; SBERVEGLIERI M; BIASIO M; GUERCIO E; JURA R; DANESE S; WIERDIS T; FARNELLI C; TARANTINO G; GRASSI R; REPETTI F; ROCCHI B; GRAMPA M; ERCOLI A; GRISO C; SIGNORI E; ZANINI L; PRESTI M; KLIMEK M; URBANSKI K; BISWAS A; VIEGAS O; KOCHLI O; DREHER E; FEY M; BECK G; LUDIN J; BONNEFOI H; KRAUER F; BAUER J; DELMORE G; FURRER C; LORENZ U; THURLIMANN B; LORENZ U; BRONZ L; SANNA P; WYSS D; GOLDHIRSCH A; GYR T; LEIDI L; PASTORELLI G; PAGANI O; REY P; HAILER U; BENZ J; KAYE SB; REED NS; SYMONDS RP; ATKINSON RJ; AXFORD AT; RUSTIN G; SECKL MJ; GREEN JA; SCOTT IV; GUTHRIE D; HARPER PG; CALMAN F; DOBBS HJ; WEIR P; CASSONI A; LEDERMAN JA; SOUHAMI RL; BOZZINO J; ADAB F; REDMAN CWE; SCOBLE JE; PATERSON M; DANIEL F; COWLEY N; WILLIAMS CJ; SPOONER D; HONG A; MCILLMURRAY M; HENDYIBBS P; HALL V; IVESON TJ; WHITEHOUSE JMA; GARRY R; LAMONT A; ROBINSON A; TRASK CW; CLUBB AW; MURRELL D; NEWMAN G; WILKINS M; GOLDTHORP WO; ROBERTS JK; RADSTONE DJ; WHIPP MJ; LEDERMANN JA; PATER J; BUYSE M; OMURA G
      ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER

      Lancet
    87. GOLDHIRSCH A
      CONSENSUS REACHED AT NEW EUROPEAN BREAST-CANCER MEETING (VOL 352, PG 1200, 1998)

      Lancet
    88. ABE O; ABE R; ENOMOTO K; KIKUCHI K; KOYAMA H; NOMURA Y; SAKAI K; SUGIMACHI K; TOMINAGA T; UCHINO J; YOSHIDA M; BENRAADT J; VANDEVELDE AO; VANDONGEN JA; VERMORKEN JB; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; COATES A; FORBES JF; FOCAN C; LOBELLE JP; GATES GD; POWELL J; DURAND M; MAURIAC L; BARTHOLOMEUS S; PICCART MJ; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; MASOOD MB; PARKER D; PRICE JJ; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; BERRY D; BROADWATER G; CIRRINCIONE C; MUSS H; NORTON L; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; GORDON NH; DAVIS HL; ROMESTAING P; LEHINGUE Y; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; PORTNOJ SM; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; COMIS RL; DAVIDSON NE; GRAY R; ROBERT N; TORMEY DC; WOOD W; CHETTY U; FORREST P; JACK W; ROSSBACH J; SYLVESTER RJ; VANDEVELDE CJH; CUNNINGHAM MP; BONNETERRE J; FUMOLEAU P; NAMER M; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; DESCHRYVER A; BELFIGLIO M; MARI E; NICOLUCCI A; SCORPIGLIONE N; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; RUBAGOTTI A; ERAZO A; MEDINA JY; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; FENTIMAN IS; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; FOUNTZILAS G; KLAFSTROM P; BLOMQVIST C; CUZICK J; MARGREITER R; CASTIGLIONE M; CAVILLI F; COLLINS J; FORBES J; GELBER RD; GOLDHIRSCH A; LINDTNER J; PRICE KN; RUDENSTAM CM; SENN HJ; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BOROVIK R; BRUFMAN G; HAYAT H; ROBINSON E; WIGLER N; PANNUTI F; TAKASHIMA S; YASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; WELVAART K; HUPPERETS PSGJ; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; INGLE JN; SUMAN VJ; BUZDAR AU; SMITH T; HAKES T; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; MYLES JD; PATER JL; PRITCHARD KI; ANDERSON S; BROWN A; BRYANT J; COSTANTINO J; DIGNAM J; FISHER B; REDMOND C; WIEAND S; WOLMARK N; JACKSON IM; PALMER MK; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; NISSENMEYER R; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; UEO H; MATHE G; MISSET JL; ABUZAHRA HT; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MORIMOTO K; SAWA K; TAKATSUKA Y; GUNDERSEN S; HAUERJENSEN M; HOST H; CROSSLEY E; HARRIS A; BEIGHTON A; CLARKE M; COLLINS R; DAVIES C; EVANS V; GODWIN J; GREAVES E; HARWOOD C; JACKSON D; JAMES S; LAU E; MEAD G; NAUGHTEN A; PETO R; TOOTH A; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPIELMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; FALKSON CI; ABRAHAM M; KLIJN JGM; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; LINDTNER A; NOTTER G; BRYANT AJS; EWING GH; KRUSHENKOSLOSKI JL; GEORGE WD; GOULD A; STEWART HJ; STRONER P; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; MARTINO S; OSBORNE CK; RAVDIN PM; RUTQVIST LE; WALLGREN A; HOLM LE; THURLIMANN B; BRENNER H; HERCBERGS A; YOSHIMOTO M; DEBOER G; PATERSON AHG; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLE M; SENANAYAKE F; BERGH J; HOLMBERG L; SEVELDA P; ZIELINSKY CC; GNANT M; JAKESZ R; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
      POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS

      Lancet
    89. Aapro, M; Goldhirsch, A
      New paradigms in the treatment of advanced breast cancer - Introduction

      SEMINARS IN ONCOLOGY
    90. GOLDHIRSCH A; COATES AS; COLLEONI M; GELBER RD
      RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER

      The New England journal of medicine
    91. COLLEONI M; AUDISIO RA; DEBRAUD F; FAZIO N; MARTINELLI G; GOLDHIRSCH A
      PRACTICAL CONSIDERATIONS IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA

      Drugs
    92. PINDER SE; MURRAY S; ELLIS IO; TRIHIA H; ELSTON GW; GELBER RD; GOLDHIRSCH A; LINDTNER J; CORTESFUNES H; SIMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M; GUSTERSON BA
      THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY

      Cancer
    93. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GALLIGIONI E; MARINI G; THURLIMANN B; FORBES JF; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
      FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS

      British Journal of Cancer
    94. GOLDHIRSCH A; GLICK JH; GELBER RD; SENN HJ
      MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER

      Journal of the National Cancer Institute
    95. LAFFER U; HARDER F; JAGGI P; METZGER U; AEBERHARD P; EGELI R; ARMA S; BARRAS JP; LAMPERT VD; MARTINOLI S; MULLER W; SCHRODER R; VONHUBEN R; WEBER W; CASTIGLIONE M; GOLDHIRSCH A; MAIBACH R; SCHMITZ SFH; GLOOR F; STAMM B; WALTZER U
      ASSOCIATION BETWEEN BLOOD-TRANSFUSION AND SURVIVAL IN A RANDOMIZED MULTICENTER TRIAL OF PERIOPERATIVE ADJUVANT PORTAL CHEMOTHERAPY IN PATIENTS WITH COLORECTAL-CANCER

      The European journal of surgery
    96. COLLEONI M; GRAFFEO R; MARTINELLI G; GHIELMINI M; DEBRAUD P; ZAMPINO G; MARINI G; CAVALLI F; GOLDHIRSCH A
      CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS

      Oncology Reports
    97. GOLDHIRSCH A
      PREOPERATIVE AND POSTSURGICAL TREATMENT

      Breast
    98. THURLIMANN B; CASTIGLIONE M; HSUSCHMITZ SF; CAVALLI F; BONNEFOI H; FEY MF; MORANT R; LOHNERT T; GOLDHIRSCH A
      FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/

      European journal of cancer
    99. CASTIGLIONEGERTSCH M; TATTERSALL M; HACKING A; GOLDHIRSCH A; GUDGEON A; GELBER RD; LINDTNER J; COATES A; COLLINS J; ISLEY M; SENN HJ; RUDENSTAM CM
      RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY

      European journal of cancer
    100. COLLEONI M; GRAFFEO R; MARTINELLI G; GHIELMINI M; MARINI G; CAVALLI F; GOLDHIRSCH A
      CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS

      European journal of cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 07:13:22